To include your compound in the COVID-19 Resource Center, submit it here.

Reslizumab: Phase III data

Data from a pair of nearly identical, double-blind, international Phase III trials in patients with inadequately controlled moderate to severe asthma with elevated levels of blood eosinophils showed

Read the full 280 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE